[go: up one dir, main page]

ES2088371B1 - PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS. - Google Patents

PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS.

Info

Publication number
ES2088371B1
ES2088371B1 ES9500180A ES9500180A ES2088371B1 ES 2088371 B1 ES2088371 B1 ES 2088371B1 ES 9500180 A ES9500180 A ES 9500180A ES 9500180 A ES9500180 A ES 9500180A ES 2088371 B1 ES2088371 B1 ES 2088371B1
Authority
ES
Spain
Prior art keywords
animals
glycoprotein
procedure
herpesvirus type
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9500180A
Other languages
Spanish (es)
Other versions
ES2088371A1 (en
Inventor
Xavier Rebordosa
Jaume Pinol
Josep-Antoni Perez-Pons
Jordi Naval
Jorge Lloberas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Hipra SA
Original Assignee
Laboratorios Hipra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hipra SA filed Critical Laboratorios Hipra SA
Priority to ES9500180A priority Critical patent/ES2088371B1/en
Publication of ES2088371A1 publication Critical patent/ES2088371A1/en
Application granted granted Critical
Publication of ES2088371B1 publication Critical patent/ES2088371B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO UTILIZADO PARA LA PRODUCCION EN FORMA RECOMBINANTE DE ANTIGENOS CORRESPONDIENTES A LA GLICOPROTEINA GE DEL HERPESVIRUS BOVINO TIPO 1 Y SU USO EN LA DIFERENCIACION SEROLOGICA ENTRE ANIMALES INFECTADOS Y VACUNADOS. EL PROCEDIMIENTO COMPRENDE LA SELECCION DE AQUELLOS SEGMENTOS DEL GEN DE LA GLICOPROTEINA GE DE HERPESVIRUS BOVINO TIPO 1 QUE PUEDEN SER EXPRESADOS EN UN VECTOR PROCARIOTA, LA EXPRESION DE DICHAS SECUENCIAS Y LA UTILIZACION DE LOS POLIPEPTIDOS RESULTANTES. LA PROTEINA RECOMBINANTE PRODUCIDA PUEDE UTILIZARSE PARA LA GENERACION DE ANTICUERPOS, EL DIAGNOSTICO DE LA RINOTRAQUEITIS INFECCIOSA BOVINA Y LA DIFERENCIACION SEROLOGICA ENTRE ANIMALES INFECTADOS Y ANIMALES VACUNADOS.PROCEDURE USED FOR THE RECOMBINANT PRODUCTION OF ANTIGENS CORRESPONDING TO THE GLYCOPROTEIN GE OF THE BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED AND VACCINATED ANIMALS. THE PROCEDURE INCLUDES THE SELECTION OF THOSE SEGMENTS OF THE GENE OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 THAT CAN BE EXPRESSED IN A VECTOR PROKARIAT, THE EXPRESSION OF SUCH SEQUENCES AND THE USE OF THE RESULTING POLYPEPTIDES. THE RECOMBINANT PROTEIN PRODUCED CAN BE USED FOR THE GENERATION OF ANTIBODIES, THE DIAGNOSIS OF THE INFECTIOUS BOVINE RHINOTRAQUEITIS AND THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS.

ES9500180A 1995-02-01 1995-02-01 PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS. Expired - Fee Related ES2088371B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9500180A ES2088371B1 (en) 1995-02-01 1995-02-01 PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9500180A ES2088371B1 (en) 1995-02-01 1995-02-01 PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS.

Publications (2)

Publication Number Publication Date
ES2088371A1 ES2088371A1 (en) 1996-08-01
ES2088371B1 true ES2088371B1 (en) 1997-04-16

Family

ID=8289320

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9500180A Expired - Fee Related ES2088371B1 (en) 1995-02-01 1995-02-01 PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS.

Country Status (1)

Country Link
ES (1) ES2088371B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
NL9100989A (en) * 1991-06-07 1993-01-04 Stichting Centr Diergeneeskund BOVINE HERPESVIRUS TYPE 1 DELETION MUTANTS, VACCINES BASED ON THESE, DIAGNOSTIC KITS FOR DETECTION OF BOVINE HERPESVIRUS TYPE 1.

Also Published As

Publication number Publication date
ES2088371A1 (en) 1996-08-01

Similar Documents

Publication Publication Date Title
ATE198754T1 (en) ANTIBODIES TO MAMMAL INTERLEUKIN-4 AND PEPTIDES USED AS ANTIGENS FOR THEIR PRODUCTION
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
AR086483A2 (en) EXPRESSION VECTOR, GUEST CELL, METHOD TO PREPARE AN ANTIGEN POLYPEPTIDE, METHOD AND EQUIPMENT FOR THE DETECTION OF A POLINUCLEOTIDE, ANTIBODY, METHOD OF USE OF AN ANTIBODY METHOD, AND USE FOR THE MANUFACTURE OF A MODULAR DEVELOPMENT MODEL OR FABRIC CULTURE CELLS
DK0757717T3 (en) papillomavirus vaccines
ES2056817T5 (en) TRANSFORMATION OF TRICHODERMA.
IL102687A0 (en) Method for enhancing immunogenicity
ES2111167T3 (en) PEPTIDIC COMPOUNDS.
ES2138784T3 (en) SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES AGAINST THE HEPATITIS C VIRUS.
HUP9902438A2 (en) Parapoxvirus vectors
YU79491A (en) VARIANT CD44-SURFACE PROTEINS, DNA-SEQUENCES ENCODING THEM AND ANTIBODIES AGAINST THESE PROTEINS
BR9810907A (en) Monoclonal and polyclonal antibodies, peptide capable of generating an antibody, immunogenic agent, nucleotide sequence, pharmaceutical composition, use of at least one antibody, diagnostic kit, and process for preparing an immunogenic agent
DK549188A (en) Lymphocyte Inhibitor HLA Peptides
DK0575317T3 (en) Recombinant anticoccidy vaccine
ES2143996T3 (en) PEPTIDIC ANTIGENS OF HCV AND PROCEDURE FOR THE DETERMINATION OF HCV.
PT625157E (en) EPITOPES P1A1 AND P1A2 OF PLATELET GPIIIA ITS PREPARATION AND UTILIZATION
ES2088371B1 (en) PROCEDURE FOR THE RECOMBINANT PRODUCTION OF ANTIGENS OF THE GLYCOPROTEIN GE OF BOVINE HERPESVIRUS TYPE 1 AND ITS USE IN THE SEROLOGICAL DIFFERENTIATION BETWEEN INFECTED ANIMALS AND VACCINATED ANIMALS.
AR014647A1 (en) A LIPL32 EXTERNAL MEMBRANE PROTEIN LIPL32 POLYPEPTIDE, AN ISOLATED POLINUCLEOTIDE, AN EXPRESSION VECTOR, A GUED CELL, A METHODOPARA TO PRODUCE SUCH LIPL32 POLYPEPTIDE, USE OF A POLIPEPTIDE MANUFACTURER, A MANUFACTURED MANUFACTURE
ES2037795T3 (en) PROCEDURE FOR THE PREPARATION OF ANTIGEN HRPII FROM PLASMODIUM FALCIPARUM SGE2.
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
IT1262898B (en) PROTEIN RECOMBINANT ANTIGENS WITH INCREASED IMMUNOGENICITY CONTAINING THE PEPTIDE REPRESENTED BY THE VQGEESNDK SEQUENCE
FI870501A (en) A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors, and host cells useful therein
AU525042B2 (en) Ovulation enhancing peptides
BR0016740A (en) Cryptosporidium sporozoite antigens

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19960801

Kind code of ref document: A1

Effective date: 19960801

FD2A Announcement of lapse in spain

Effective date: 20180806